Literature DB >> 12036604

Cloning the cDNA for murine U2 snRNP-A' gene and its differential expression in lymphocyte development.

Mariastefania Antica1, Borka Kusic, Dubravka Hranilovic, Allan B Dietz, Stanimir Vuk-Pavlovic.   

Abstract

We studied genes differentially transcribed during development of murine thymocytes. By the use of differential display of mRNA by polymerase chain reaction (DD-PCR) we identified a cDNA for U2snRNP-A' from a transcript abundant in precursor thymocytes, but rare in mature T cells. The transcript was fully cloned and found to be 97% homologous to the human cDNA for U2 snRNP-A'. We found the gene most abundantly transcribed on day 15 of gestation and in adult prothymocytes, spleen, testis and liver. Further characterization of snRNP proteins in the mouse is warranted in an effort to establish animal models of autoimmunity relevant for studies of connective tissue diseases or systemic lupus erythematosus, where patients harbor autoantibodies reactive to snRNP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036604     DOI: 10.1016/s0165-2478(02)00064-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

Review 1.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

2.  A Novel Drug Combination of Mangiferin and Cinnamic Acid Alleviates Rheumatoid Arthritis by Inhibiting TLR4/NFκB/NLRP3 Activation-Induced Pyroptosis.

Authors:  Weijie Li; Kexin Wang; Yudong Liu; Hao Wu; Yan He; Congchong Li; Qian Wang; Xiaohui Su; Shikai Yan; Weiwei Su; Yanqiong Zhang; Na Lin
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

3.  MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer.

Authors:  Wen-Cui Li; Yan-Qiong Wu; Bo Gao; Chao-Yun Wang; Juan-Juan Zhang
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.